Lord, Abbett & Co. LLC

SEC CIK: 0000728100
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

RVNC holding history

Revance Therapeutics, Inc. in every 13F filed by Lord, Abbett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RVNC overview All 13F holders of RVNC Full Q2 2026 holdings

Shares (Q3 2023): 0; Sold out in Q3 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2023

Holdings of RVNC by Lord, Abbett & Co. LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2023	0	$0	0.0%	−1,248,586−100.0%	Sold out	Holders
Q2 2023	1,248,586	$31.6M	0.1%	+1,016,810+438.7%	Added	Holders
Q1 2023	231,776	$7.46M	<0.1%	+231,776	New	Holders